AzTrials
AzTrials

Breastfeeding Mothers of Infants HospitalizedPOOL-BMNCT02994823

The "Pooling" Expressed Breast Milk: A Method for Improving the Nutritional Intake of Premature Infants

An observational study of Breastfeeding Mothers of Infants Hospitalized, run by University Hospital, Brest at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The investigators compared a pooled mother's expressed breastmilk for 24 hours with individual pump session collection of milk to provide a more consistent caloric product without increasing bacterial contamination. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
How many people
10 participants
Where
1 siteFrance
Study dates
Jun 2015to Dec 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Breastfeeding mothers of infants hospitalized

Who may be able to join

  • Mother of newborn hospitalized in intensive care unit
  • Mother using a breast pump in the unit and / or at home
  • Mother respected the rules of handling and transport breastmilk
  • No opposition mother

Who cannot join

  • refusal

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHUR de Brest

    Brest, 29609

Other trials in France

About this study

The investigators compared a pooled mother's expressed breastmilk for 24 hours with individual pump session collection of milk to provide a more consistent caloric product without increasing bacterial contamination.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. caloric value of breastmilk

    The caloric value will be compared between the two groups (pooled expressed breastmilk versus individual expressed breastmilk)

    Measured: at the end of each 24 hours collection from inclusion to the end of collection during 4 days

Secondary outcomes (1)
  1. bacterial contamination of breastmilk

    The bacterial contamination of breastmilk will be compared between the two groups with the value for colony-forming units per milliliter (cfu/mL) after plating on sheep blood agar and Chapman's agar.

    Measured: at the end of each 24 hours collection from inclusion to the end of collection during 4 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2016 (estimated)
  2. Study startJun 2015
  3. Primary completionSep 2015
  4. Study completionDec 2016

Why it stopped: prolonged device failure after just 10 participants and too long to resume

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02994823
Sponsor's protocol ID
POOL-BM
Acronym
POOL-BM
Status last verified
Jan 2020
First submitted
2 Sep 2016
Last updated
18 Jan 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Breastfeeding Mothers of Infants Hospitalized, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: prolonged device failure after just 10 participants and too long to resume). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

caloric value of breastmilk (time frame: at the end of each 24 hours collection from inclusion to the end of collection during 4 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in